Cidara Therapeutics, Inc.
CDTX
Classificação em ações
#3189
Cidara Therapeutics, Inc. is a biotechnology company specializing in the... Cidara Therapeutics, Inc. is a biotechnology company specializing in the creation, advancement, and commercialization of extended-duration anti-infective drugs. Their mission targets the prevention and treatment of infectious diseases and certain cancers within the U.S. Their primary therapeutic candidate, rezafungin acetate, is an innovative echinocandin antifungal designed to combat and avert severe fungal infections such as candidemia and invasive candidiasis, conditions known for their high fatality rates. Additionally, Cidara utilizes its Cloudbreak platform to engineer conjugated therapies aimed at preventing and treating influenza as well as various other viral illnesses, including respiratory syncytial virus (RSV), human immunodeficiency virus (HIV), and SARS-CoV-2, the pathogen behind COVID-19. Originally incorporated in 2012 as K2 Therapeutics, Inc., the company adopted its current name, Cidara Therapeutics, Inc., in July 2014. Its operations are headquartered in San Diego, California.
Preço da ação
$221.38
Última sincronização: 2026-01-08
Valor de mercado
$5.61B
Variação (1 dia)
0.00%
Variação (1 ano)
114.47%
País
US
Negociar Cidara Therapeutics, Inc. (CDTX)
Categoria
Healthcare
Histórico de preços das ações de Cidara Therapeutics, Inc. (CDTX)
Preço de fecho mais alto: $221.30 em 2026-01-01
Preço de fecho mais baixo: $300.77 em 2015-04-01
Preço de fecho mais baixo: $300.77 em 2015-04-01
Histórico de preços das ações da Cidara Therapeutics, Inc. de 2015 a 2026
Desempenho anual do preço das ações
| Ano | Desempenho |
|---|---|
| 2026 (TTM) | -17.55% |
| 2025 | 886.34% |
| 2024 | 47.58% |
| 2023 | 30.93% |
| 2022 | -59.17% |
| 2021 | -32.54% |
| 2020 | -21.59% |
| 2019 | -2.71% |
| 2018 | -62.52% |
| 2017 | -30.69% |
| 2016 | -35.78% |
| 2015 | 0.00% |
Preço das ações de empresas similares ou concorrentes
| Empresa | Preço da ação | Variação 1a% | País |
|---|---|---|---|
| $518.20 | 21.57% |
US
|
|
| $243.77 | 786.76% |
US
|
|
| $138.33 | -3.31% |
AU
|
|
| $879.20 | 5.32% |
NL
|
|
| $752.87 | 7.40% |
CH
|
